NCT01910662 arm group 9c29efbdac5360ea8eff07a433e1472c [clinicaltrials_resource:NCT01910662/arm-group/9c29efbdac5360ea8eff07a433e1472c]
arm group [clinicaltrials_vocabulary:arm-group]
NCT01910662 arm group 9c29efbdac5360ea8eff07a433e1472c [clinicaltrials_resource:NCT01910662/arm-group/9c29efbdac5360ea8eff07a433e1472c]
Bio2RDF identifier
NCT01910662/arm-group/9c29efbdac5360ea8eff07a433e1472c
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... 29efbdac5360ea8eff07a433e1472c
description [clinicaltrials_vocabulary:description]
Subjects in the Part B Cohort ...... first 3 subjects in Cohort 1).
identifier
clinicaltrials_resource:NCT01910662/arm-group/9c29efbdac5360ea8eff07a433e1472c
title
NCT01910662 arm group 9c29efbdac5360ea8eff07a433e1472c
@en
type
label
NCT01910662 arm group 9c29efbd ...... 9efbdac5360ea8eff07a433e1472c]
@en